ACIU — AC Immune AG Share News
0.000.00%
Last trade - 00:00- $249.35m
- $163.15m
- CH₣3.57m
Brief: Ac Immune Says Informed Enrollment Has Been Temporarily Paused For Phase 2B Retain Trial
U.S. STOCKS ON THE MOVE-Walt Disney, Titan Mining, Costco Wholesale
U.S. STOCKS ON THE MOVE-Nordson, Walt Disney, Titan Mining
U.S. STOCKS ON THE MOVE-Roku, Ciena, Diamond Hill
AC Immune jumps after Parkinson's treatment shows promise in mid-stage study
Brief: AC Immune Positive Interim Phase 2 Data On ACI-7104.056 Support Potential Slowing Of Progression Of Parkinson’s Disease
NASDAQ RESUMED AT 07:30 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
AC Immune SA reports results for the quarter ended June 30 - Earnings Summary
Brief: AC Immune Q2 Operating Income CHF -19.388 Million
AC Immune SA expected to post a loss of 17 rappen a share - Earnings Preview
Brief: AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Brief: AC Immune SA - ACI-7104.056 Is Well Tolerated With No Safety Issues Reported To Date
AC Immune SA reports results for the quarter ended December 31 - Earnings Summary
AC Immune SA expected to post a loss of 19 rappen a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Talen Energy, Biogen, Ovintiv
U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, Sonos
U.S. STOCKS ON THE MOVE-Walt Disney, Hilton, Oklo
AC Immune rises on interim mid-stage data for Parkinson's therapy